Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), today announced an exclusive licensing agreement for the development and commercialisation of givinostat in Japan. Under the ...
As the year draws to a close and the new year looms, the industry takes out its collective crystal ball for a look at what 2026 has in store for AI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback